Biotech

All Articles

Neurocrine's proposal to conserve mental illness prospect neglects

.Neurocrine Biosciences' mental illness plan pivot has fallen short. The biotech was not able to dup...

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has brought in an overdue entrance to the radioligand party, paying one hundred thousand eur...

F 2G brings up $100M for 2nd effort to obtain brand-new antifungal to market

.After F2G's first attempt to obtain a new course of antifungal to market was actually hindered due ...

Moderna targets $1.1 B in R&ampD spending cuts, drops 5 systems surrounded by productivity tensions

.Moderna has sworn to cut R&ampD spending by $1.1 billion through 2027. The choice to shrink the fin...

Sanofi's $80M bet on Fulcrum dystrophy medication ends in stage 3 crash

.Merely 4 months after Sanofi wager $80 million in beforehand cash money on Key Therapies' losmapimo...

Oncternal assets drains 60% amidst discharges, test discontinuations

.Cancer cells business Oncternal Therapies is actually folding all its own clinical trials and layin...

Roche is supporting out chances that its injectable being overweight prospect might at some point demonstrate 25% fat burning in late-stage test

.Roche is keeping out chances that its injectable excessive weight prospect might ultimately illustr...

Novo Nordisk hails 'exceptional' weight management lead for dual-acting dental drug in early trial

.Novo Nordisk has lifted the top on a stage 1 test of its dental amylin and also GLP-1 receptor co-a...

AbbVie files suit BeiGene over blood stream cancer drug secret method

.Just a few short full weeks after gaining an FDA Fast Track tag for its own investigational BTK deg...

Lilly supplies one-two hit with second tranche of good data on weekly the hormone insulin candidate

.Not long after a good information decline for Eli Lilly's efsitora alfa, the Indianapolis-based bus...